News from all angles
(MedPage Today) -- Drugmaker Novartis acknowledged Thursday that there have been nine reports of tumors in children treated with its gene therapy onasemnogene abeparvovec (Zolgensma) for spinal muscu…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network